Nádia Emi Aikawa - Concepedia

Author

Nádia Emi Aikawa

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo ORCID

Also Known As

Aikawa, Nádia Emi, Ana P. Sakamoto, Elisa Terezinha, M. Bijl, N Aikawa, N E Aikawa, Nádia E. Aikawa, N. Aikawa, N. E. Aikawa, N.E. Aikawa

355

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo Universidade de São Paulo Universidade Federal de São Paulo Universidade Estadual Paulista (Unesp)Universidade Estadual de Campinas (UNICAMP)

About

Nádia Emi Aikawa is an author at Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo specializing in medicine, immunology, and rheumatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	24	940
2	Public Health	4	4	220
3	Allergy	3	3	129
4	Clinical Immunology	1	1	17
5	Environmental Health	1	1	142

Nádia Emi Aikawa

Publications

Citations

H-Index

Page 1

	Year	Citations
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial Ana Cristina de Medeiros Ribeiro, Nádia Emi Aikawa, Carla Gonçalves Schahin Saad, Nature Medicine VaccinationRheumatologyVaccine SafetyAutoimmune Rheumatic DiseasesAutoimmune Disease	2021	214
Vitamin D Supplementation in Adolescents and Young Adults With Juvenile Systemic Lupus Erythematosus for Improvement in Disease Activity and Fatigue Scores: A Randomized, Double‐Blind, Placebo‐Controlled Trial Glauce Leão Lima, Juliane Aline Paupitz, Nádia Emi Aikawa, Arthritis Care & Research	2015	155
Epidemiological and outcome characteristics of major burns in Tokyo K. Kobayashi, Hiroto Ikeda, Ryouhei Higuchi, Burns EpidemiologyFire SafetyEnvironmental HealthFire ProtectionBurn Management	2004	142
Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases Carla Gonçalves Schahin Saad, Eduardo Ferreira Borba, Nádia Emi Aikawa, Annals of the Rheumatic Diseases	2011	103
Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice Ana Cristina de Medeiros Ribeiro, Lissiane Karine Noronha Guedes, Júlio César Bertacini de Moraes, Annals of the Rheumatic Diseases	2011	96
Hypertension in employees of a University General Hospital Décio Mion, Ângela Maria Geraldo Pierin, Alberto P. Bambirra, Revista do Hospital das Clínicas	2004	83
Glucocorticoid: Major Factor for Reduced Immunogenicity of 2009 Influenza A (H1N1) Vaccine in Patients with Juvenile Autoimmune Rheumatic Disease Nádia Emi Aikawa, Lúcia Maria Arruda Campos, Clóvis A. Silva, The Journal of Rheumatology ImmunodeficienciesImmunologyFlu VaccinationGlucocorticoid UseInfluenza Vaccines	2011	79
High Disease Activity: An Independent Factor for Reduced Immunogenicity of the Pandemic Influenza A Vaccine in Patients With Juvenile Systemic Lupus Erythematosus Lúcia Maria Arruda Campos, Clóvis A. Silva, Nádia Emi Aikawa, Arthritis Care & Research	2013	73
TNF blockers show distinct patterns of immune response to the pandemic influenza A H1N1 vaccine in inflammatory arthritis patients Ana Cristina de Medeiros Ribeiro, Nádia Emi Aikawa, Carla Gonçalves Schahin Saad, Lara D. Veeken	2012	70
Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy? Eduardo Ferreira Borba, Carla Gonçalves Schahin Saad, Sandra Gofinet Pasoto, Lara D. Veeken VaccinationVaccinologySle No TherapyVaccine DevelopmentInfluenza A/h1n1 Vaccination	2012	69

Page 1